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T cells play a key role in the battle against cancer. To perform their antitumor activities, T 
cells need to adequately respond to tumor antigens by establishing contacts with either 
malignant cells or antigen-presenting cells. These latter functions rely on a series of migra-
tory steps that go from entry of T cells into the tumor followed by their locomotion in the 
tumor stroma. Our knowledge of how T cells migrate within tumors mainly comes from 
experiments performed in mouse models. Whereas such systems have greatly advanced 
our understanding, they do not always faithfully recapitulate the disease observed in 
cancer patients. We previously described a technique based on tissue slices that enables 
to track with real-time imaging microscopy the motile behavior of fluorescent T cells 
plated onto fresh sections of human lung tumors. We have now refined this approach to 
monitor the locomotion of resident tumor-infiltrating CD8 T cells labeled with fluorescently 
coupled antibodies. Using this approach, our findings reveal that CD8 T cells accumulate 
in the stroma of ovarian and lung carcinomas but move slowly in this compartment. 
Conversely, even though less populated, tumors islets were found to be zones of faster 
migration for resident CD8 T cells. We also confirm the key role played by collagen fibers, 
which, by their orientation, spacing and density, control the distribution and migration of 
resident CD8 T cells within the tumor stroma. We have subsequently demonstrated that, 
under some physical tissue constraints, CD8 T cells exhibited a mode of migration char-
acterized by alternate forward and backward movements. In sum, using an ex vivo assay 
to track CD8 T cells in fresh human tumor tissues, we have identified the extracellular 
matrix as a major stromal component in influencing T cell migration, thereby impacting 
the control of tumor growth. This approach will aid in the development and testing of 
novel immunotherapy strategies to promote T cell migration in tumors.
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of their endogenous counterpart and have allowed us to point out 
some of the obstacles that limit T cells in their capacity to get in 
close contact with tumor cells. In particular, our data reveal that 
the density and orientation of collagen fibers of the ECM control 
the distribution and migration of T cells within tumors and their 
ability to infiltrate tumor islets.
However, this approach has some limitations. It relies on T 
cell purification, which is not always possible for all the samples, 
due to the reduced size or the scarcity of T cells of some biopsies. 
In addition, we do not know whether the behavior of purified 
or peripheral blood activated T cells truly mimics the behavior 
of resident intratumoral T lymphocytes. We have thus refined 
our slice assay by using a direct staining of endogenous cells 
with fluorescent antibodies in fresh tumor slices. This allowed 
us to track for the first time the dynamics of resident CD8 T 
cells in human tumors with a combination of confocal and 
multi-photon microscopy. This novel technique also permits the 
investigation of real-time interactions between lymphocytes and 
other cell types, such as tumor or stromal cells, as well as ECM 
components.
We have thus confirmed our previous results by observing the 
same key role of the ECM in controlling endogenous CD8 T cell 
behavior in human lung cancer, and we have extended these find-
ings to another human tumor, the ovarian epithelial carcinoma. 
Our data unveil different CD8 T cell dynamics on the basis of 
their localization (stromal vs. intratumoral) and a new mode of T 
cell migration, characterized by alternate forward and backward 
movements, determined by the physical constraints of the ECM.
Materials and Methods
human Tumors
Fresh lung tumors were obtained from anonymized patients 
diagnosed with clinical stage I–III non-small cell lung cancer 
and who underwent radical lobectomy or pneumonectomy. 
No chemotherapy or radiotherapy was administered before the 
operation. Non-fixed fresh tumors obtained after the resection 
were rapidly transported to the laboratory in ice-cold RPMI 
1640. A total of 19 lung tumors were used for this study, both 
adenocarcinomas and squamous cell carcinomas, among which 
12 were discarded due to a scarcity of T cells in the tumor tis-
sue, to very high level of autofluorescence of fibers precluding 
imaging of T cells, to an unclear distinction between tumor cell 
regions and stroma and to complete immobility of CD8 T cells 
in the whole tissue. These clear qualitative differences between 
tumors were noticed after visual inspection of several micro-
scopic fields or time-lapse imaging of immunostained tumor 
slices. Fresh ovarian tumors were obtained from anonymized 
patients diagnosed with clinical stage III–IV epithelial ovarian 
cancer and who underwent exploratory laparotomy or complete 
surgery. Non-fixed fresh tumors obtained after the resection were 
rapidly transported to the laboratory in ice-cold RPMI 1640. A 
total of 15 epithelial ovarian cancers were used for this study, both 
endometrial and serous adenocarcinomas, among which 6 were 
discarded due to a scarcity of T cells in the tumor tissue, to an 
unclear distinction between tumor cell regions and stroma and to 
complete immobility of CD8 T cells in the whole tissue.
introduction
The importance of T lymphocytes in antitumor immunity is by 
now well established. In recent years, the extensive knowledge in 
this field has finally found a promising clinical translation with 
the adoptive cell transfer (ACT) of tumor antigen-specific T cells 
and the development of immune checkpoint inhibitors, as anti-
PD-1 and anti-CTLA-4, which have proven to be effective in a 
number of cancer patients (1).
Current immunotherapies mainly aim at increasing tumor-
specific T cell number or boost their cytotoxicity. However, these 
treatments do not benefit all cancer patients, revealing the presence 
of other obstacles that need to be identified. These can concern 
defects in the ability of T cells to respond to tumor antigens and a 
failure of lymphocytes to interact with malignant cells and/or with 
antigen-presenting cells. In particular, in order to exert a direct 
antitumor cytotoxic activity, T lymphocytes need not only to be 
recruited to the tumor site but should also make a direct physical 
contact with tumor cells (2) and cooperate with other immune 
partners. This T cell–tumor cell interaction is the end result of 
a number of migratory steps, that start when lymphocytes cross 
the venular wall to enter into the tumor, then migrate within the 
stroma, a complex microenvironment composed of non-cancer 
cells along with the extracellular matrix (ECM), and eventually 
make contact with malignant cells. Whereas a lot of attention 
has been paid to the extravasation step, its defects, and how to 
overcome them (3), much less is known about the intra-tumoral 
motile behavior of T cells, especially in human malignant tissues.
In mouse models, the dynamics of T cells in the tumor 
microenvironment have been followed in real time by intravital 
microscopy. Most studies have explored the behavior of adoptively 
transferred or endogenous fluorescent T cells in the early rejec-
tion phase, both by two-photon (4–9) and confocal (10) imaging. 
These experiments have shed light on how T cells migrate within 
tumors and interact with tumor cells and antigen-presenting 
cells, but they have been primarily performed with transplant-
able, antigen-specific tumor models, thus not fully recapitulating 
the situation in human cancer.
Up to the present, all the data available for T cells in human 
tumors mainly come from immunostainings performed on fixed 
tissues. These studies have revealed that growing human tumor 
T cells are usually much more abundant in the stroma compared 
to tumor islets, highlighting the presence of obstacles that limit T 
cells from infiltrating tumor cell regions (2, 11). Conversely, the 
presence of CD3+ and/or CD8+ T cells in tumor nests relative to 
stroma is correlated with a better prognosis and better response to 
therapy in several human cancers (12–17). Moreover, the notion 
that T cells are hindered in their trafficking into and within 
tumors has been supported in mice by the synergy between 
therapeutic immunotherapies and approaches that target differ-
ent components of the stroma and enhance T cell infiltration into 
tumor nests (18–21).
To gain insight into lymphocyte dynamics in a human 3D 
tumor microenvironment, we have recently developed a method 
to monitor the motility of T cells plated on top of fresh tumor tis-
sue slices (11, 22). In such conditions, exogenously added fluores-
cently labeled lymphocytes closely mimic the spatial organization 
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Human tumors were obtained with the agreement of the French 
ethical committee, and by the Assistance Publique-Hôpitaux de 
Paris (AP-HP), in application with the article L.1121-1 of French 
law. A written informed consent was obtained from the patients 
prior to inclusion in the study.
Tumor slices and immunostaining
Experiments were performed with tumor specimens obtained 
2–4  h after tumor resection. A minority of biopsies was kept 
12–24 h at 4°C before processing for imaging and similar results 
were obtained with these samples in terms of T cell motility. 
Tumor slices were prepared as described in Refs. (11, 22). In brief, 
samples were embedded in 5% low-gelling-temperature agarose 
(type VII-A, Sigma-Aldrich) prepared in PBS. 350 μm slices were 
cut with a vibratome (VT 1000S, Leica) in a bath of ice-cold PBS. 
Slices were transferred to 0.4-μm organotypic culture inserts 
(Millicell, Millipore) in 35-mm Petri dishes containing 1 ml RPMI 
1640 in an incubator at 37°C/5% CO2.
Live vibratome sections were stained for 15 min at 37°C with 
the following antibodies: PE-conjugated anti-CD8 (clone SK1, 
purchased from BD Biosciences), FITC-conjugated anti-EpCAM 
(clone HEA-125, purchased from Miltenyi) and washed thereaf-
ter. In some experiments, slices were stained with AlexaFluor647-
conjugated anti-CD8 Fab fragment (R&D Biotech). All antibodies 
were diluted in RPMI and used at a concentration of 10 μg/ml. To 
concentrate the antibodies on the tissue, a stainless steel ring was 
placed to the agarose surrounding the slice.
Time-lapse imaging
T cells were imaged with a DM500B upright microscope equipped 
with a SP5 confocal head (Leica) and a 37°C thermostated cham-
ber. For dynamic imaging, tumor slices were secured with a stain-
less steel slice anchor (Warner Instruments) and perfused at a rate 
of 1 ml/min with a solution of RPMI without phenol red, bubbled 
with 95% O2 and 5% CO2. Ten minutes later, images from a first 
microscopic field were acquired with a 25× water immersion 
objective (Olympus, 20×/0.95 NA). For four-dimensional analysis 
of cell migration, stacks of 6–10 sections (z step = 5–7 μm) were 
acquired every 30 s for 20–40 min, at depths up to 80 μm. Regions 
were selected for imaging when tumor parenchyma, stroma and 
T cells were simultaneously present in the same microscopic field. 
For most of the tumors included in the study, between 2 and 4 
microscopic fields were selected for time-lapse experiments.
For two-photon imaging, excitation was provided by a 
Chameleon Ultra Ti:Sapphire laser (Coherent). Emitted 
fluorescence was detected through 405/15 (SHG), 525/50 
(Alexa-488) and 610/50 (PE) non-descanned detectors (NDD). 
For confocal imaging, excitation was provided by an Ar laser 
(488 nm excitation) and a HeNe laser (633 nm excitation) and 
emitted fluorescence was detected in the following PMT spectra 
ranges: 500–560  nm (FITC, alexa-488), 560–630  nm (PE) and 
640–750 nm (APC, alexa-647).
Data analysis
Image analysis was performed at the Cochin Imaging Facility 
(Institut Cochin, Paris). A 3D image analysis was performed on 
x, y, and z planes using Imaris 7.4 (Bitplane AG). First, superficial 
planes from top of the slice to 15 μm in depth were removed to 
exclude T cells located near the cut surface. Cellular motility 
parameters were then calculated using Imaris. Tracks >10% of the 
total recording time were included in the analysis. The straight-
ness value was calculated as the ratio of the distance from origin 
to the total distance traveled. To reveal the relationship between 
CD8 T cell motility and the tumor structure (tumor islets and 
collagen network), confocal time-lapse images of T cells were 
superimposed onto the corresponding SHG and EpCAM images. 
CD8 T cells localized in the stroma were distinguished from those 
infiltrated in tumor cell nests by looking at individual planes along 
the z axis. Videos and images were made by compressing the z 
information into a single image using Imaris. When a drift in the 
x, y dimension was noticed, it was corrected using the “Correct 
3D Drift” plug-in in ImageJ. For the automated detection of resi-
dent CD8 T cells in different tumor areas (stroma, tumor islets, 
loose, and dense collagen regions identified by visual inspection 
of SHG images), we used the ImageJ software. First, fluorescent 
images were thresholded and converted to binary images. Angles 
between the cell trajectory vectors, which are the connecting lines 
between starting points and end points of each track, and tumor-
stroma boundaries were calculated using Image J software. Only 
the cells positioned within a maximum distance of 100 μm from 
the tumor-stroma interfaces were included in further analysis. 
Distances between collagen fibers were determined by using the 
“point to point distance measurement” function of Imaris.
statistical analysis
We first used a Kolmogorov–Smirnov normality test (one sample 
test) to determine whether data values distributed normally. 
When values were not normally distributed, an unpaired two-
tailed non-parametric Mann–Whitney test was performed 
to determine statistical significance. When values followed a 
Gaussian distribution, an unpaired t-test was performed to 
determine statistical significance. All these statistical analysis 
were performed with Prism 6 (GraphPad). *P < 0.05; **P < 0.01; 
***P < 0.001.
results
Tracking resident cD8 T cell Motility in human 
Tumors
In order to track the dynamic behavior of resident CD8 T cells in 
human ovarian and lung tumors, we have modified our previously 
described slice preparation (11). A fragment of tumor rapidly 
obtained after surgical resection was embedded in agarose and 
sliced into 350 μm-thick sections with a vibratome (Figure 1A). 
Unfixed slices were then labeled with fluorescently coupled 
anti-CD8 and anti-EpCAM antibodies to visualize CD8 T cells 
and tumor epithelial cells, respectively. The fibrillar collagen was 
assessed without exogenous staining by using second-harmonic 
generation (SHG).
Time-lapse experiments were first performed with a two-pho-
ton microscope. Stacks of images from the cut surface to 80 μm 
in depth were captured sequentially every 15–30 s for 20 min. A 
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representative example of CD8 T cell distribution and migration 
in ovarian tumor slices is shown in Figure 1B and Movie S1 in 
Supplementary Material. The structure is typical of a carcinoma, 
with well-delineated and compact tumor islets positive for 
EpCAM, surrounded by a stroma enriched in collagen. Resident 
CD8 T cells were preferentially found in the stroma, with some 
of them being actively motile (see also Figure 2). However, with 
two-photon imaging a pronounced photobleaching occurred and 
after 5 min of recording the fluorescence signal of CD8 T cells was 
largely decreased. As this rather fast bleaching of the organic dyes 
complicated the analysis of T cell dynamics, we decided to switch 
to confocal microscopy. Movie S2 in Supplementary Material 
and Figure 1C show that the photobleaching was considerably 
reduced using this approach. In this setting, stacks of EpCAM 
and CD8 images from the cut surface to 80 μm in depth were 
recorded over 20–30 min with the confocal mode. Then, at the 
end of the recording, one stack of SHG images was captured with 
the two-photon mode and superimposed to the EpCAM and CD8 
stack of images.
A
B C
D
FigUre 1 | Tracking resident cD8 T cell motility in human tumors. (a) Experimental setup. Tissue slices were prepared from human lung and ovarian tumors 
by means of a vibratome. Slices were then stained with conjugated antibodies and imaged through confocal and two-photon microscopy. (B) Snapshots of 
two-photon images of an ovarian tumor slice stained for CD8 (green) and EpCAM (blue) to identify tumor cell regions. SHG (red) was used to visualize the collagen 
network. See also Movie S1 in Supplementary Material. (c) Snapshots of confocal images of an ovarian tumor slice stained for CD8 (green) and EpCAM (blue) to 
identify tumor cell regions. Second-harmonic generation images (red) captured with a two-photon microscope were superimposed to the confocal images. See also 
Movie S2 in Supplementary Material. (D) Snapshots of confocal images of an ovarian tumor slice stained with the indicated antibodies and captured at different 
depths from the cut surface. See also Movies S3 and S4 in Supplementary Material.
Given the size of antibodies, it was important to make sure 
that they could efficiently penetrate the tumor tissue. Figure 1D 
shows confocal planes of a microscopic field captured at 3, 16, 
32, and 48 μm below the cut surface of a slice labeled for CD8 and 
EpCAM. Even if the fluorescence signal of anti-CD8 antibody 
was stronger in the superficial region of the slice (3 μm), CD8 T 
cells were still easily detected deeper within the tissue, at depths 
up to 50 μm. In line with our previous study in murine lymph 
nodes (23), we noted that a large proportion of CD8 T cells in the 
superficial regions of the slice was round and stationary (Movie 
S3 in Supplementary Material), likely reflecting a tissue damage 
associated with the slicing procedure. Accordingly, a large frac-
tion of cells at the cut surface of the slice was labeled with DAPI, 
a nuclear dye that only penetrates cells whose plasma membrane 
is damaged (data not shown). However, below 15 μm of depth, 
virtually all motile and sessile CD8 T cells were viable (Movie S4 
in Supplementary Material and data not shown).
These results demonstrate that antibody labeling of unfixed 
human tumor slices combined with confocal and two-photon 
AC
E
B
D
F
FigUre 2 | Distribution and migration of resident cD8 T cells in human ovarian and lung tumors. (a,B) Distribution of resident CD8 T cells in human 
ovarian tumors. (a) Representative image of a human ovarian tumor slice stained for EpCAM (blue) and CD8 (green). The SHG signal is in red. (B) Concentration of 
resident CD8 T cells in the stromal and tumor cell regions of human ovarian carcinomas. Left panel: CD8 density in stromal (red) and tumor cell (blue) regions for 
individual tumors. Numbers indicate the fold increase of CD8 T cells in stromal regions over tumor islets. Right panel: pooled values, median ± interquartile range. 
(c,D) Motility of resident CD8 T cells in human ovarian tumors. (c) Trajectories of individual resident CD8 T cells in the stromal (red) and tumor cell (blue) regions of a 
human ovarian carcinoma slice. See also Movie S5 in Supplementary Material. The slice was stained with the indicated antibodies and imaged for 30 min with a 
confocal microscope. The SHG signal was recorded at the end with a two-photon microscope. Tracks are color-coded according to CD8 T cell displacement 
length. (D) Left panel: medians of mean velocities of resident CD8 T cells in the stromal and tumor cell regions of individual human ovarian carcinomas. Right panel: 
pooled values, medians ± interquartile. (e,F) Motility of resident CD8 T cells in human lung tumors. (e) Trajectories of individual resident CD8 T cells in the stromal 
(red) and tumor cell (blue) regions of a human lung carcinoma slice. The slice was stained with the indicated antibodies and imaged for 20 min with a confocal 
microscope. The SHG signal was recorded at the end with a two-photon microscope. Tracks are color-coded according to CD8 T cell displacement length. (F) Left 
panel: medians of mean velocities of resident CD8 T cells in the stromal and tumor cell regions of individual human lung carcinomas. Right panel: pooled values, 
medians ± interquartile. Mann–Whitney test, *P < 0.05; **P < 0.01; ***P < 0.001.
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microscopy enabled to dynamically monitor resident CD8 T cells 
in a native three-dimensional tumor environment, with minimal 
photobleaching and without the need for T cell purification, 
staining and plating. This setting, which has the advantage to 
examine T cells in human tumors under physiological conditions, 
was subsequently used to perform an in-depth analysis of CD8 T 
cell distribution and migration in ovarian and lung carcinomas.
resident cD8 T cell Distribution and Migration 
in human Ovarian and lung Tumors
Our previous study conducted on non-small cell lung tumors 
revealed the preferential accumulation of endogenous and 
plated T cells in the stroma rather than in the tumor epithelial 
compartment (11). Here, we analyzed the localization and motile 
behavior of endogenous CD8 T cells in different regions of ovar-
ian carcinomas.
In ovarian carcinomas, CD8 T cells were preferentially 
enriched in the stroma and rarely found in EpCAM+ tumor cell 
regions (Figure  2A), as previously observed in lung tumors. 
Analysis performed in slices from nine different human ovarian 
tumors showed on average five times more CD8 T cells in the 
stroma compared to tumor islets (Figure 2B). Notably, some large 
variations from one tumor to another were observed, with some 
tumors showing tumor islets nearly devoid of CD8 T cells.
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We then determined the motile behavior of resident CD8 T 
cells in the stroma and tumor cell regions of slices from ovarian 
carcinomas. The motility of CD8 T cells localized in the stroma 
was rather low, with a median of mean velocity of 4.04 μm/min 
(Figures  2C,D and Movie S5 in Supplementary Material). We 
also quantified the percentage of migrating cells, defined as cells 
with a mean velocity higher than 5 μm/min during a 20-min 
recording. Data from nine different ovarian tumors indicated 
that 37% of CD8 T cells were motile. Large variations were noted 
from one tumor to the other, with proportion of migrating 
CD8 T cells ranging from 20 to 60%. Of interest, the few CD8 
T cells located in tumor islets migrated more rapidly than those 
found in the stroma with a median of mean velocity of 5.16 μm/
min (Figure  2D and Movie S6 in Supplementary Material). 
We confirmed these findings in lung tumors (Figures  2E,F). 
In the stroma of lung tumors, the median of mean velocity was 
3.27 μm/min, whereas in tumor islets the velocity was two-fold 
higher (6.53 μm/min). The difference between these velocities 
is significant (P  <  0.0001). Highly motile CD8 T cells were 
deeply infiltrated into tumor islets, as shown in Movies S7 and 
S8 in Supplementary Material that represent T cell dynamics in 
individual z planes.
Since full-sized antibodies have, in principle, the potential to 
bind to Fc receptors and to transmit signals that can significantly 
impact T cell motility, we also performed experiments with a 
fluorescently labeled Fab fragment directed against CD8 that con-
firmed the conclusions drawn with full-sized antibodies. Thus, 
as shown in Movie S9 in Supplementary Material, most CD8 T 
cells in the stroma of an ovarian tumor slice displayed low or no 
motility, with only rare cells migrating.
These results indicate that in ovarian and lung carcinoma, 
resident CD8 T cells preferentially accumulate in the stroma, and 
move slowly in this region. Conversely, even though less popu-
lated, tumors islets were found to be zones of faster migration for 
resident CD8 T cells.
collagen Fibers control the Distribution and 
Migration of cD8 T cells in the stroma of human 
Ovarian carcinoma
The motility of CD8 T cells in the stroma does not only depend on 
T cell properties and response to chemokines, but also on external 
constraints that may limit interstitial lymphocyte migration. We 
have previously demonstrated the importance of the structure of 
the stroma in the distribution and migration of plated T cells in 
human lung tumors (11). Here, we examined the organization 
of the collagen network in ovarian tumors and their influence 
on CD8 T cell distribution and migration. Collagen-rich regions 
were frequently observed in the stroma of ovarian carcinomas 
(Figure 3A). Our data indicate that dense regions contained less 
CD8 T cells than loose-collagen areas, as the number of CD8 T 
cells in defined stromal areas was inversely correlated with the 
amount of collagen in the same areas (Figure 3B). Likewise, the 
motility of CD8 T cells in dense collagen regions of the stroma 
was decreased compared to porous collagen regions, where fast 
moving cells were frequently observed (Figure  3C and Movie 
S10 in Supplementary Material). Figures 3D,E and Movie S11 in 
Supplementary Material illustrate the motile behavior of one resi-
dent CD8 T cell that migrates rapidly in a loose-collagen region 
and then reduces its velocity when encountering an obstacle 
composed of a bundle of dense collagen fibers. Notably, not all 
CD8 T cells were motile in loose-collagen areas, likely reflecting 
the presence of elements other than the ECM that limit T cells in 
their displacements.
As previously described in lung tumors, the fast moving CD8 T 
cells often exhibited straight migration paths. A close examination 
revealed that these cells follow precisely the pre-defined collagen 
scaffold and often migrate between two fibers, as if confined into 
a conduit (Figure 3F and Movie S12 in Supplementary Material). 
We then quantified the motile behavior of CD8 T cells in relation 
to collagen fiber linearity. In organized and linear matrix areas, 
CD8 T cells migrated in a relatively linear fashion, as based on 
straightness indices close to 0.6 on average (Figure 3G). By con-
trast, these indices were much smaller when CD8 T cells were 
tracked in non-organized collagen fibers. Overall, our results 
indicate that in human ovarian carcinomas a fibrous stroma can 
act both as a physical barrier and a guidance structure for resident 
CD8 T cells.
Back and Forth Migration of resident cD8 T 
cells in the stroma of human Ovarian 
carcinomas
In some ovarian tumor biopsies (four out of nine), we noted the 
presence of motile CD8 T cells that exhibited back and forth 
migration (Figure 4A and Movies S13 and 14 in Supplementary 
Material). Characteristic aspects of this behavior were phases of 
migration along a straight path, interrupted by short migration 
pauses during which CD8 T cells reoriented their locomotion 
machinery and migrated in the opposite direction. These alternate 
forward and backward movements can be repeated a number of 
times during a 20 min recording. Among motile CD8 T cells in 
these four ovarian tumors, 20–40% of the tracks displayed this 
type of locomotion. Notably, this mode of migration was rarely 
observed in lung tumors. We found that this type of cell move-
ment was strongly dependent on the structure of the stromal col-
lagen network and in particular on its porosity. Our data indicate 
that CD8 T cells with alternate forward and backward motion 
migrate in a conduit-like structure, with pore sizes ranging 
between 4 and 7 μm (Figure 4B). The available spaces between 
collagen fibers perfectly accommodate the moving T cell body. 
In other regions, the structure of the collagen network was very 
different, with CD8 T cells migrating randomly where the spacing 
between two fibers was significantly higher (11.79 ± 1.207 μm). 
These findings led us to postulate a mechanism by which space 
restriction constrains the movement of CD8 T cells in the tumor 
stroma and forces them to migrate with alternate forward and 
backward movements.
The collagen structure surrounding Tumor 
islets controls the capacity of cD8 T cells to 
contact Tumor cells
In human lung tumors, we previously demonstrated that the pres-
ence of a dense collagen network, composed of thick and linear 
A B C
D E
F
G
FigUre 3 | collagen fibers control the distribution and migration of cD8 T cells in the stroma of human ovarian carcinoma. (a) Human ovarian tumor 
slice stained for CD8 (green) and EpCAM (blue), showing accumulation of resident CD8 T cells in collagen-loose regions. Collagen (red) has been imaged through 
SHG. (B) Automatically counted number of resident CD8 T cells in different 50 μm × 50 μm stromal regions classified according to the surface (%) occupied by 
collagen detected through SHG. Results were obtained on slices from four different ovarian tumors. (c) Left panel: mean velocities of resident CD8 T cells in loose 
and dense collagen areas of individual human ovarian carcinomas. Right panel: pooled values, mean ± SD. (D–g) Motile behavior of resident CD8 T cells relative to 
collagen fibers. (D) Snapshots are shown at various time intervals for the same CD8 T cell. The trajectory of this CD8 T cell was superimposed over SHG images. 
The track is color-coded according to the instantaneous velocity. See also Movie S11 in Supplementary Material. (e) Velocity of the CD8 T cell represented in (D).  
(F) Snapshots are shown at various time intervals for the same CD8 T cell located in a linear collagen region. The trajectory of the CD8 T cell was superimposed 
over SHG images. The track is color-coded according to the instantaneous velocity. See also Movie S12 in Supplementary Material. (g) The graph shows the 
straightness index of individual tracks of CD8 T cells in linear and non-linear collagen fiber regions. Straightness indices close to 1 correspond to linear trajectories. 
Values are compiled from four different ovarian tumors. Mann–Whitney test, *P < 0.05; **P < 0.01; ***P < 0.001.
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ECM fibers surrounding tumor islets, limits T cell trafficking (11). 
From this study, we suggest that these concentric surrounding 
structures, that we have termed ring structures, observed in some 
but not all human lung carcinomas, contribute to keeping T cells 
in the stroma, away from tumor cells. One important question is 
whether such signature is a specific feature of lung carcinomas or 
is also observed in other solid malignancies. We thus examined 
the organization of the collagen network adjacent to tumor islets 
in ovarian carcinomas and their influence on resident CD8 T cells. 
Analysis performed on nine ovarian tumors showed the presence 
of such ring structures composed of dense and parallel collagen 
fibers surrounding tumor islets, in three tumors (Figure 5A left 
panel). In all the other tumors, the collagen network most proximal 
to tumor cells did not show a particular organization (Figure 5A 
right panel). In some tumors, the SHG signal was dim with small 
fibers oriented in no particular direction. In one tumor, strands 
of collagen were even found penetrating into the tumor mass. 
We then monitored the motility of T cells in these organized and 
non-organized peritumoral areas. Resident CD8 T cell motility 
tracked in organized peritumoral regions displayed trajectories 
mostly parallel to the tumor-stroma interface (Figure  5A left 
panel and Movie S15 in Supplementary Material). The situation 
was strikingly different in non-organized peritumoral regions, 
with T cell tracks that were randomly distributed (Figure  5A 
right panel). To quantify the CD8 T cell motility pattern in organ-
ized and in non-organized peritumoral areas, we analyzed the 
trajectory vectors of individual lymphocytes, i.e., the connecting 
lines between starting point and end point of each track (11). 
A B
FigUre 4 | Back and forth migration of resident cD8 T cells in the stroma of human ovarian carcinomas. (a) Representative image of a resident CD8 T 
cell that exhibits a back and forth migration mode relative to collagen fibers. See also Movie S13 in Supplementary Material. Left: SHG signal (red) alone. Dotted 
lines indicate the spacing between collagen fibers. Right: same SHG image as in left but with a CD8 T cell (green) and its trajectory (white line) during a 17-min 
recording. (B) Spacing between collagen fibers are shown for CD8 T cells that display either back and forth or random migration. The durations of the tracks were 
non-significantly different within the two groups (13.5 ± 2.6 min for CD8 T cells that exhibit back and forth migration vs. 16.8 ± 2.6 min for CD8 T cells that migrate 
randomly). Values are compiled from four different ovarian tumors. t-test, *P < 0.05; **P < 0.01; ***P < 0.001.
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Measurement of the smallest angle between the vector and the 
tumor-stroma boundary resulted in values substantially smaller 
than 45° (26.8 ± 7.18°, n = 12 cells, Figure 5B) when CD8 T cells 
were in peritumoral ring structures. In contrast, widely distrib-
uted angles resulting in average values close to 45° (53.8 ± 6.52°, 
n = 13 cells), thus indicating a random migration, were observed 
when T cells migrated in non-organized peritumoral areas. The 
random migration of CD8 T cells in non-organized peritumoral 
areas prompted us to investigate the dynamics of lymphocytes 
navigating from the stroma to tumor islets. The migration of CD8 
T cells through these distinct microenvironments is supposed to 
be important for an effective destruction of tumor cells. Analysis 
of velocities of the few CD8 T cells at the stroma-tumor boundary 
did not reveal marked speed changes when T cells crossed this 
boundary. Large speed fluctuations were observed when T cells 
migrated within the stroma and similar variations occurred once 
T cells reached tumor cell regions (Figures 5C,D and Movie S16 
in Supplementary Material).
We conclude that the architecture of the collagen network 
surrounding tumor islets likely contribute to dictate the migra-
tion of resident CD8 T cells and their ability to contact tumor 
cells. In absence of ring structures, CD8 T cells seem to be able 
to migrate without hindrance from the stroma to tumor islets.
Discussion
For an effective direct destruction of cancer cells, CD8 T cells 
must fulfill several functions. First, they should be able to migrate 
efficiently into and within tumors in order to make contact with 
malignant cells and antigen-presenting cells. Second, they should 
be able to respond adequately to tumor antigens by releasing 
cytotoxic granules. In cancer patients, accumulating evidence 
suggests that both T cell trafficking and responsiveness to tumor 
antigens are altered (2). Whereas a lot of efforts have been made 
to overcome T cell exhaustion, boosting lymphocyte activation 
alone would not be enough if T cells cannot migrate and reach 
tumor cells. It is therefore important to understand the cellular 
and molecular processes underlying T cell motility within tumors 
in order to optimize the current immunotherapeutic strategies 
aiming at increasing T cell cytotoxicity. Here, we have used 
and refined our previously described slice assay to examine the 
migration of resident CD8 T cells in progressing human ovarian 
and lung tumors. Our imaging study uncovered several novel 
findings.
First, we observed that in ovarian carcinomas CD8 T cells are 
much more numerous in the stromal compartments than in tumor 
islets. This result extends the observations that we had initially 
made in human lung carcinomas. It is in line with previous stud-
ies in which CD8 T cells have been shown to be similarly enriched 
in the stroma of a large number of human solid malignancies, 
including ovarian carcinomas (2, 14). Of interest, the number of 
CD8 T cells presents in tumor cell regions of ovarian tumors was 
correlated with a better outcome (14). Additionally, a recent study 
revealed that the exclusion of T cells from tumor islets predicts 
unresponsiveness to anti-PD-1 treatment in some cancer patients 
(17). Thus, the trapping of T cells into the stroma appears to be 
a general feature of growing solid tumors and may be associated 
with immunsuppression.
Our data also indicate that a large proportion of T cells slowly 
migrate in the stromal compartment. The slow migration of a 
large number of CD8 T cells is consistent with previous studies 
showing an altered migratory pattern of T cells during states 
of functional impairment. For instance, during persistent viral 
infection T cells were found to be in a state of motility paralysis 
(24). Likewise, by looking at the dynamics of endogenous T cells 
in progressively growing murine tumors, Mrass et  al. reported 
a low T cell motility (4), a finding recently confirmed in two 
different murine tumor models (8, 9). In contrast, an increased 
T cell motility within tumors is associated with successful 
immunotherapy treatments (4, 9). Among the different reasons 
A B
C
D
FigUre 5 | The structure of the collagen around tumor islets dictates the migration of resident cD8 T cells. (a) Representative images of resident CD8 T 
cells migrating in peritumoral areas surrounded by ring (left) and non-ring (right) structures. See also Movie S15 in Supplementary Material. Tracks (green lines) and 
trajectory vectors (white arrows) during a 20-min recording are also shown. Dotted lines denote tumor–stroma interface. (B) Angle between tumor–stroma boundary 
and trajectory vector of individual CD8 T cells during a 20-min recording, measured in peritumoral regions with ring or non-ring fibrillar structures. Dashed line 
denotes 45°, the expected result from a cell population migrating with no directional bias. Values were from four different ovarian tumor specimens. (c) 
Representative image of a CD8 T cell that migrates from the stroma to the tumor cell region in a specimen devoid of ring structure around tumor islets. The track of 
the CD8 T cells is color-coded according to the instantaneous velocity. See also Movie S16 in Supplementary Material. (D) Velocity of the CD8 T cell represented in 
(c). Mann–Whitney test, *P < 0.05.
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that contribute to explain the relative poor motility in growing 
tumors, a lack of migration cues including chemokines, TCR 
stimulation, and costimulatory molecules have been put forward 
(18, 25). One hallmark of progressive tumors is the deposition 
of a dense collagen network, which has been long recognized to 
support cancer cell growth and metastatic dissemination (26). 
Moreover, there is now compelling evidence demonstrating that 
dense collagen structures hinder antitumor immune responses, 
including T cell migration. In human lung tumors, our published 
study indicated that T cell positioning and migration was mark-
edly reduced in matrix-rich stromal regions (11). Likewise, in 
pancreatic carcinomas, one of the most fibrotic tumors, T cells 
accumulate in areas of low-density collagen, far from tumor islets 
(15, 27). In addition, by comparing the recruitment of T cells into 
various murine metastatic melanomas following chemotherapy, 
Tan et al. made the interesting observation that T cell infiltration 
only occurred in tumors whose stroma exhibited a loose matrix 
architecture (28). In our study, we extended these findings to 
resident CD8 T cells in ovarian and lung carcinomas that are 
also characterized by an extensive collagen-rich stroma. Of note, 
most of these studies are correlative and at present we do not 
known whether an altered ECM is directly responsible for the 
poor capacity of T cells to migrate within the tumor stroma. An 
exaggerated ECM deposition is not only a hallmark of growing 
tumors, but also of fibrotic tissues. Interestingly, a negative role 
of a dense ECM on T cell immune surveillance was recently 
reported during liver fibrosis (29).
The tumor stroma is a complex and heterogeneous micro-
environment composed of cells and elements that cooperate to 
influence, either positively or negatively, T cell migration (30). 
Along with very dense matrix areas, some stromal regions are 
also characterized by organized and linear collagen fibers that 
guide T cells in their displacements. Accordingly, a large pro-
portion of motile CD8 T cells in the stroma exhibited straight 
migratory paths along collagen fibers. Notably, some linearly 
migrating lymphocytes also display alternate forward and 
backward movements, especially when positioned between 
two collagen fibers with gap sizes that accommodate the T cell 
body. This type of “back and forth” migration which, to our 
knowledge, has never been reported for lymphocytes, presents 
some analogies with that described for macrophages in dense 
collagen gels (31). In this setting, macrophages have been shown 
to generate a persistent tunnel, via proteases, which is further 
used by the following macrophages to migrate rapidly and 
often with oscillatory movements. T cells, known to migrate 
in a MMP-independent manner, might use similar tunnels 
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previously generated by other cells using their proteases. Why 
T cells exhibit such oscillatory behavior when present in these 
“tubes” is unknown too. Even if we cannot rule out the pres-
ence of obstacles – dense ECM or unlabeled cells – that would 
force T cells to stop and reorient their locomotion machinery, 
we favor the existence of a constraining structure, in which 
chemokines are present (there is a marked T cell motility), but 
without gradient (there is no directionality). T cell motility 
parameters, such as speed and propensity to turn, have also 
been shown to be cell-intrinsic (32). For instance, when placed 
in large micro-channels, T cells did not show persistent migra-
tion along the channel, but instead switched from one wall to 
another (33). Two-photon imaging studies have also confirmed 
the fact that T cells exhibit, in a number of tissues, repetitive 
straight runs, followed by periods of pauses (34). This “stop 
and go” mode of migration has been recognized to facilitate 
the detection of rare expressed antigens by naïve T cells in 
lymphoid organs and the rapid search of target cells by effector 
T cells in inflamed tissues. In tumors, the prevalence of linear 
collagen structures along with dense collagen networks may 
constrain such T cell search strategy and thus compromise 
tumor immunosurveillance.
These ECM structures present around tumor islets will also 
be important in controlling the infiltration of T cells into tumor 
islets. By analyzing T cell dynamics in lung and ovarian tumors 
in which islets were surrounded or not by adjacent collagen 
strands, our data support the notion that a ring structure is 
detrimental for CD8 T cells to migrate from the stroma to tumor 
cell regions, in line with our previous study (11). In absence of 
such determinants, we observed some T cells that enter into 
tumor islets without particular deceleration. Apart from a key 
role played by the ECM, additional mechanisms might also be 
operative in preventing T cells from contacting tumor cells. A 
recent study has proposed that the paucity of T cells observed 
in tumor islets of pancreatic adenocarcinoma was due to the 
presence of CXCL12 in cancer cell regions, creating a chemical 
barrier against T cells (19). Depending on the tumor type, the 
crossing of the tumor-stroma boundary might be favored or 
hindered by a number of structural and molecular determinants 
including a chemokine gradient (either attractive or repulsive) 
and physical constraints.
Once passed these barriers, we have observed that the rare 
T cells in tumor islets migrate more actively in these compart-
ments than in the stroma. Thus, tumor cell regions cannot be 
considered as unfavorable migration zones for CD8 T cells, 
at least for some of them. This process might show some 
analogies to the crossing of T cells through activated venular 
walls, where lymphocytes undergo profound shape changes to 
extravasate (35).
Altogether, our data support the notion that the structure of 
stromal ECM has overall a negative influence on resident CD8 T 
cells, limiting their migration in the stroma and preventing them 
from contacting tumor cells. These mechanisms may impede 
endogenous antitumor immune responses and should be con-
sidered in the development of novel immunotherapy strategies. 
Particularly relevant to this issue is the recent report of chimeric 
antigen receptor T cells engineered to express ECM-degrading 
enzymes that has shown good infiltration into tumors and anti-
tumor efficacy (36).
The approach that we have developed offers a number of 
interesting perspectives in a context of human tumor immunol-
ogy. T cells, as well as other cells for which antibodies have been 
generated, can be imaged with excellent specificity and their 
interplays studied in real time. For instance, the monitoring of 
particular subsets of T cells, including activated and exhausted 
lymphocytes, with antibodies directed against specific markers 
like PD-1 represents a promising strategy.
This experimental system also presents some limitations that 
need to be kept in mind. Damage associated with the slicing may 
affect T cell functioning, especially in the superficial region of 
the tissue near the cut surface. We have bypassed this problem by 
imaging cells located at several tens of microns from the surface, 
in presumably healthier regions of the tissue. Another potential 
concern is the use of full-sized antibodies that can affect the 
behavior of the tracked cells. We have no indication that our data 
were affected by such problems, since CD8 T cells exhibited a 
good motility that very much depends on the tumor environment 
and in particular on the structure of the ECM. We confirmed 
some of our results with Fab fragments of anti-CD8 that present 
several advantages compared to full-sized antibodies. Small 
molecules and devoid of a Fc region, Fab fragments probably 
penetrate more efficiently into tissues, without binding to cells 
that express Fc receptors. Although Fab fragments, like full-sized 
antibodies, keep their ability to modulate the interaction between 
CD8 and MHC class I molecules, they are poorly able to transmit 
an intracellular activation signal capable of altering the T cell 
behavior. The recent use of camelid-derived antibody fragments, 
much smaller than Fab fragments, represents an interesting 
alternative strategy to image the progress of an immune response 
in live tissues (37).
It is clearly established that the immunosuppressive environ-
ment of solid tumors limits the migration and functions of T 
lymphocytes and therefore their antitumor activities. Prior to 
initiating clinical trials, model systems in which novel immuno-
therapeutic molecules can be characterized and tested for their 
potency and safety should be available. So far, most of these 
assays are based on in vitro cell culture systems that poorly mimic 
the complexity of the tumor tissue. We believe that the approach 
we have developed  –  tracking of immunostained CD8 T cells 
in fresh human tumor tissue with imaging technology – could 
be used as pre-clinical model system in which novel immuno-
therapy treatments and especially those designed to boost T cell 
migration can be assessed and optimized in conditions close to 
the clinic.
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